IRX 26.7% 3.8¢ inhalerx limited

The Curious Case of Lifespot, page-44

  1. 755 Posts.
    lightbulb Created with Sketch. 186
    @sidage

    You correctly picked up that they spent almost 5 times more on "travel, employee and fringe benefits" than they did on project costs.

    What you failed to pick up is that they spent another $539,000 on "Consulting Fees" which is commonly a euphemism for director's fees.

    Further to that, what is most disappointing, there appears to be plenty of talk about developing high-tech products both historically and now, but there expenditure on "Product Development" was only $7,600.

    I hate to sound negative, but surely I am not the only one who is noticing that the pecuniary benefits afforded to directors seem to outweigh the expenditure on product development and direct project costs?
 
watchlist Created with Sketch. Add IRX (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.008(26.7%)
Mkt cap ! $8.024M
Open High Low Value Volume
3.5¢ 3.8¢ 3.2¢ $20.74K 590K

Buyers (Bids)

No. Vol. Price($)
1 125000 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 50000 1
View Market Depth
Last trade - 14.07pm 15/11/2024 (20 minute delay) ?
IRX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.